Our client sought to merge its own OTC pharma division with a competitor. If successful this would form the world’s largest OTC joint venture pharma company by market share – particularly in the key markets of North America, China and Europe.

The joint venture was complex in size and nature, posing a large risk for both of the JV partners. It was essential to ensure that customer commitments were met when facing the following challenges:

  • Delivering global deployment plans with consideration of supply chain routes, antitrust legislation and unique local legislation.
  • Integrating the target division’s processes, people, trading and data into the client’s own division.
  • Seeking agreement between the two parties on acceptable cutover processes and principles.
  • Working with the necessary antitrust bodies to ensure compliance.
  • Managing the collaborations with multiple organisations effectively – the client, the target organisation, regulatory bodies and other providers.
  • Integrating the two parties against the backdrop of the COVID-19 pandemic.

Providing a team of delivery and solutions consultants to manage the complexities of the program and deliver a seamless joint venture integration.

Our approach included:

  • Delivering an effective and realistic global deployment plan for integration activities.
  • Driving a flexible delivery approach to respond with agility to a changing environment and customer demand during the COVID-19 pandemic.
  • Working effectively with multi-disciplinary teams to drive the right outcome.
  • Providing an experienced and pragmatic approach to antitrust challenges.
  • Providing a transparent and knowledgeable approach to cutover and stock transfers.
  • Effectively partnering with both the client and the JV partner to integrate functions successfully and mitigating supply chain risks.
  • Managing stakeholder expectations across both companies at a corporate and local level.
  • 90% of trade has been integrated into the JV and all operations are working in harmony.
  • Business continuity maintained from day 1, with no impact to customers, despite the challenges of COVID-19.

Neil Littlejohn

Founder & Executive Director

Facing similar challenges in your business?

To speak to one of our experts and discuss how Helixr can help your business, please get in touch via our contact form.

  • This field is for validation purposes and should be left unchanged.